CGNT

Cognyte Software Ltd.

70
Fundamentals69/ 100
Valuation50/ 100
Upside potential61/ 100
Risk potential34/ 100

CGNT's outlook is improving, though it still trails on the overall score.

MU

Micron Technology, Inc.

96
Fundamentals95/ 100
Valuation91/ 100
Upside potential93/ 100
Risk potential15/ 100

MU has the edge over CGNT overall, supported by stronger valuation and stronger modeled upside.

CGNT Fundamentals

MetricStatus
Healthy
Stable
Healthy
Strong

CGNT's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.

MU Fundamentals

MetricStatus
Strong
Strong
Strong
Strong

MU's revenue, profitability, cash flow and balance sheet are all currently strong.

CGNT PE Valuation

CGNT has no meaningful PE right now: it lost money over the past year.

MU PE Valuation

CHEAPFAIREXPENSIVE42x83x125x166x
CHEAPFAIREXPENSIVE42x83x125x166x
LevelPEPriceVs current
Forward4.6x$798—
Cheap10x$777-2.7%
Current11x$798—
Fair22x$1,646+106%
Expensive32x$2,404+201%

Historical ranges are pointers, not guarantees.

MU's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 4.6x next year's earnings.

CGNT Forward outlook

MetricOutlook
--
Strong growth
Growth
Strongly improving
Limited
High

Analysts expect earnings and revenue growth for CGNT, with profitability improving.

MU Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly improving
Broad
Moderate

Analysts expect strong earnings and revenue growth for MU, with profitability improving.

CGNT Risk to reward

ScenarioChangePrice
Upside+53%$12.82
Downside-34%$5.53

Calculated from the latest close: $8.38 on Nov 12.

CGNT trails MU on modeled risk to reward, with less potential upside and more potential downside.

MU Risk to reward

ScenarioChangePrice
Upside+219%$2,544.93
Downside-15%$674.73

Calculated from the latest close: $798.44 on Nov 12.

MU has a better modeled risk to reward balance than CGNT, with more potential upside and less potential downside.

CGNT Earnings Per Share

Q4 2023: $-0.57Q1 2024: $-0.20Q2 2024: $-0.17Q3 2024: $-0.06Q4 2024: $-0.19Q1 2025: $-0.17Q2 2025: $-0.11Q3 2025: $-0.06Q4 2025: $-0.08Q1 2026: $-0.01Q2 2026: $-0.04Q3 2026: $0.00Forward: $0.70
Q4 2023: $-0.57Q1 2024: $-0.20Q2 2024: $-0.17Q3 2024: $-0.06Q4 2024: $-0.19Q1 2025: $-0.17Q2 2025: $-0.11Q3 2025: $-0.06Q4 2025: $-0.08Q1 2026: $-0.01Q2 2026: $-0.04Q3 2026: $0.00Forward: $0.70
QuarterTTM EPSYoY
Forward$0.70—
Q3 2026-$0.00+$0.06
Q2 2026-$0.04+$0.07
Q1 2026-$0.01+$0.16
Q4 2025-$0.08+$0.11
Q3 2025-$0.06$0.00
Q2 2025-$0.11+$0.06
Q1 2025-$0.17+$0.03
Q4 2024-$0.19+$0.38

CGNT lost $0.00 per share over the past year, a smaller loss than the year before.

MU Earnings Per Share

Q4 2023: $-6.28Q1 2024: $-3.45Q2 2024: $-1.42Q3 2024: $0.70Q4 2024: $3.49Q1 2025: $4.19Q2 2025: $5.57Q3 2025: $7.59Q4 2025: $10.52Q1 2026: $21.18Q2 2026: $44.17Q3 2026: $74.33Forward: $174.95
Q4 2023: $-6.28Q1 2024: $-3.45Q2 2024: $-1.42Q3 2024: $0.70Q4 2024: $3.49Q1 2025: $4.19Q2 2025: $5.57Q3 2025: $7.59Q4 2025: $10.52Q1 2026: $21.18Q2 2026: $44.17Q3 2026: $74.33Forward: $174.95
QuarterTTM EPSYoY
Forward$174.95+135%
Q3 2026$74.33+879%
Q2 2026$44.17+693%
Q1 2026$21.18+405%
Q4 2025$10.52+201%
Q3 2025$7.59+984%
Q2 2025$5.57+$6.99
Q1 2025$4.19+$7.64
Q4 2024$3.49+$9.77

MU has the edge over CGNT on earnings, with more consistent year-over-year improvement.

CGNT Quarterly Revenue

Q4 2023: $79MQ1 2024: $84MQ2 2024: $83MQ3 2024: $84MQ4 2024: $89MQ1 2025: $95MQ2 2025: $96MQ3 2025: $98MQ4 2025: $101MQ1 2026: $106MQ2 2026: $105MQ3 2026: $109M
Q4 2023: $79MQ1 2024: $84MQ2 2024: $83MQ3 2024: $84MQ4 2024: $89MQ1 2025: $95MQ2 2025: $96MQ3 2025: $98MQ4 2025: $101MQ1 2026: $106MQ2 2026: $105MQ3 2026: $109M
QuarterRevenueYoY
Q3 2026$109.2M+12%
Q2 2026$105.5M+10%
Q1 2026$106.2M+12%
Q4 2025$100.7M+13%
Q3 2025$97.5M+16%
Q2 2025$95.5M+16%
Q1 2025$94.5M+13%
Q4 2024$89M+12%

CGNT's revenue has grown year over year for 12 quarters in a row: $109M last quarter, up 12% from the same quarter a year ago.

MU Quarterly Revenue

Q4 2023: $4.7BQ1 2024: $5.8BQ2 2024: $6.8BQ3 2024: $7.8BQ4 2024: $8.7BQ1 2025: $8.1BQ2 2025: $9.3BQ3 2025: $11.3BQ4 2025: $13.6BQ1 2026: $23.9BQ2 2026: $41.5BQ3 2026: $54.2B
Q4 2023: $4.7BQ1 2024: $5.8BQ2 2024: $6.8BQ3 2024: $7.8BQ4 2024: $8.7BQ1 2025: $8.1BQ2 2025: $9.3BQ3 2025: $11.3BQ4 2025: $13.6BQ1 2026: $23.9BQ2 2026: $41.5BQ3 2026: $54.2B
QuarterRevenueYoY
Q3 2026$54.2B+379%
Q2 2026$41.5B+346%
Q1 2026$23.9B+196%
Q4 2025$13.6B+57%
Q3 2025$11.3B+46%
Q2 2025$9.3B+37%
Q1 2025$8.1B+38%
Q4 2024$8.7B+84%

MU has the edge over CGNT on sales, with stronger typical year-over-year growth.

CGNT Free Cash Flow

Q4 2023: −$2MQ1 2024: $7MQ2 2024: $20MQ3 2024: −$8MQ4 2024: $8MQ1 2025: $14MQ2 2025: −$2MQ3 2025: −$9MQ4 2025: $23MQ1 2026: $19MQ2 2026: −$6MQ3 2026: −$1M
Q4 2023: −$2MQ1 2024: $7MQ2 2024: $20MQ3 2024: −$8MQ4 2024: $8MQ1 2025: $14MQ2 2025: −$2MQ3 2025: −$9MQ4 2025: $23MQ1 2026: $19MQ2 2026: −$6MQ3 2026: −$1M
QuarterFree cash flowYoY
Q3 2026-$1.5M+$7.4M
Q2 2026-$6.1M-$3.7M
Q1 2026$19.2M+33%
Q4 2025$22.8M+199%
Q3 2025-$8.9M-$836K
Q2 2025-$2.5M-113%
Q1 2025$14.4M+106%
Q4 2024$7.6M+$9.9M

CGNT usually generates cash, though not every quarter: the latest was −$1M, but it generated $34M over the past year.

MU Free Cash Flow

Q4 2023: −$395MQ1 2024: −$165MQ2 2024: $396MQ3 2024: $285MQ4 2024: $38MQ1 2025: −$113MQ2 2025: $1.7BQ3 2025: $72MQ4 2025: $3BQ1 2026: $5.5BQ2 2026: $17.6BQ3 2026: $32.9B
Q4 2023: −$395MQ1 2024: −$165MQ2 2024: $396MQ3 2024: $285MQ4 2024: $38MQ1 2025: −$113MQ2 2025: $1.7BQ3 2025: $72MQ4 2025: $3BQ1 2026: $5.5BQ2 2026: $17.6BQ3 2026: $32.9B
QuarterFree cash flowYoY
Q3 2026$32.9B+45543%
Q2 2026$17.6B+951%
Q1 2026$5.5B+$5.6B
Q4 2025$3B+7853%
Q3 2025$72M-75%
Q2 2025$1.7B+322%
Q1 2025-$113M+$52M
Q4 2024$38M+$433M

MU has the edge over CGNT on cash flow, with more consistent year-over-year improvement.

CGNT Total Shares

Q4 2023: 71MQ1 2024: 71MQ2 2024: 71MQ3 2024: 72MQ4 2024: 72MQ1 2025: 72MQ2 2025: 72MQ3 2025: 74MQ4 2025: 73MQ1 2026: 75MQ2 2026: 73MQ3 2026: 73M
Q4 2023: 71MQ1 2024: 71MQ2 2024: 71MQ3 2024: 72MQ4 2024: 72MQ1 2025: 72MQ2 2025: 72MQ3 2025: 74MQ4 2025: 73MQ1 2026: 75MQ2 2026: 73MQ3 2026: 73M
PeriodChange %Net change
Quarterly0%--
1 year-1.4%-1.1M shares
3 years+4.2%+2.9M shares
5 years+10%+6.7M shares
Available history+11%+7.4M shares

CGNT has the edge over MU on shareholder dilution, with a more favorable share count trend.

MU Total Shares

Q4 2023: 1.1BQ1 2024: 1.1BQ2 2024: 1.1BQ3 2024: 1.1BQ4 2024: 1.1BQ1 2025: 1.1BQ2 2025: 1.1BQ3 2025: 1.1BQ4 2025: 1.1BQ1 2026: 1.1BQ2 2026: 1.1BQ3 2026: 1.1B
Q4 2023: 1.1BQ1 2024: 1.1BQ2 2024: 1.1BQ3 2024: 1.1BQ4 2024: 1.1BQ1 2025: 1.1BQ2 2025: 1.1BQ3 2025: 1.1BQ4 2025: 1.1BQ1 2026: 1.1BQ2 2026: 1.1BQ3 2026: 1.1B
PeriodChange %Net change
Quarterly-0.2%-2M shares
1 year+1.6%+18M shares
3 years+4.6%+50M shares
5 years+0.2%+2M shares
Available history+1.2%+14M shares

MU has 1.1B diluted shares, up 1.6% from a year ago.

CGNT Net Leverage

Q2 2024: -60.1xQ3 2024: -10.2xQ4 2024: -147.5xQ1 2025: -8.2xQ2 2025: -4.8xQ3 2025: -3.3xQ4 2025: -3.6xQ1 2026: -3.1xQ2 2026: -3.3xQ3 2026: -2.7x
Q2 2024: -60.1xQ3 2024: -10.2xQ4 2024: -147.5xQ1 2025: -8.2xQ2 2025: -4.8xQ3 2025: -3.3xQ4 2025: -3.6xQ1 2026: -3.1xQ2 2026: -3.3xQ3 2026: -2.7x
QuarterNet LeverageStatus
Q3 2026-2.7xNet Cash
Q2 2026-3.3xNet Cash
Q1 2026-3.1xNet Cash
Q4 2025-3.6xNet Cash
Q3 2025-3.3xNet Cash
Q2 2025-4.8xNet Cash
Q1 2025-8.2xNet Cash
Q4 2024-147.5xNet Cash

CGNT has the edge over MU on leverage, with a lower net debt burden relative to earnings.

MU Net Leverage

Q4 2023: 5.0xQ1 2024: 1.6xQ2 2024: 0.9xQ3 2024: 0.7xQ4 2024: 0.6xQ1 2025: 0.5xQ2 2025: 0.3xQ3 2025: 0.3xQ4 2025: 0.1xQ1 2026: -0.1xQ2 2026: -0.3xQ3 2026: -0.3x
Q4 2023: 5.0xQ1 2024: 1.6xQ2 2024: 0.9xQ3 2024: 0.7xQ4 2024: 0.6xQ1 2025: 0.5xQ2 2025: 0.3xQ3 2025: 0.3xQ4 2025: 0.1xQ1 2026: -0.1xQ2 2026: -0.3xQ3 2026: -0.3x
QuarterNet LeverageStatus
Q3 2026-0.3xNet Cash
Q2 2026-0.3xNet Cash
Q1 2026-0.1xNet Cash
Q4 20250.1xVery low
Q3 20250.3xVery low
Q2 20250.3xVery low
Q1 20250.5xVery low
Q4 20240.6xVery low

MU has more cash than debt.

CGNT Weekly Momentum

MetricValueStatus
RSI46.8Neutral
Stochastic29.4Neutral

CGNT's weekly RSI is 47 (neutral) and its Stochastic is 29 (neutral).

MU Weekly Momentum

MetricValueStatus
RSI47.1Neutral
Stochastic26.9Neutral

MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).

CGNT PE vs Technology Sector

MetricCGNTSector medianRelative
PEN/A28x—

CGNT has no meaningful PE right now: it lost money over the past year.

MU PE vs Technology Sector

MetricMUSector medianRelative
PE11x28x61% below
PE %183517 pts below

MU is trading at 11x earnings, a 61% discount to the Technology sector's median of 28x.

CGNT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$8.804.8% below
20 week MA$8.744.1% below
50 week MA$8.835.1% below
100 week MA$8.946.3% below
200 week MA$7.4612% above

CGNT has fallen below most of its moving averages, though it's still 12% above its 200-week average.

MU Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$914.513% below
20 week MA$931.014% below
50 week MA$685.916% above
100 week MA$405.497% above
200 week MA$246.0225% above

MU has the edge over CGNT on trend strength, trading above more of its moving averages.

CGNT Yearly ROI

YearStart priceEnd priceROI
2021$28.8$14.9-48%
2022$14.9$2.75-82%
2023$2.75$6.43+134%
2024$6.43$8.77+36%
2025$8.77$9.31+6.2%
2026 YTD$9.31$8.38-10%

CGNT's yearly returns have swung widely, from +134% in 2023 to −82% in 2022. It's down 10% so far in 2026.

MU Yearly ROI

YearStart priceEnd priceROI
2020$54.0$70.6+31%
2021$70.6$94.4+34%
2022$94.4$50.2-47%
2023$50.2$85.3+70%
2024$85.3$88.6+3.9%
2025$88.6$284.8+221%
2026 YTD$284.8$798.4+180%

MU has the edge over CGNT on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key